Periprocedural blood pressure management in neurointerventional surgery

Journal of NeuroInterventional Surgery

Volumn 3, Issue 1, 2011, Pages 66-73

  Leslie Mazwi, Thabele M ^a   Sims, John R ^a   Hirsch, Joshua A ^a   Nogueira, Raul G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLEVIDIPINE; DEXMEDETOMIDINE; DIHYDROPYRIDINE; DOBUTAMINE; DOPAMINE; ENALAPRILAT; ESMOLOL; FIBRINOLYTIC AGENT; HYDRALAZINE; LABETALOL; NICARDIPINE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENYLEPHRINE; PROPOFOL; REMIFENTANIL; SEVOFLURANE;

ARTERIAL PRESSURE; ARTERIOVENOUS MALFORMATION; ARTICLE; AUTOREGULATION; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRAIN ARTERY ANEURYSM; BRAIN BLOOD FLOW; BRAIN MICROCIRCULATION; BRAIN VASOSPASM; CARDIOVASCULAR PARAMETERS; CAROTID ARTERY OBSTRUCTION; CLINICAL DECISION MAKING; CONSCIOUS SEDATION; DRUG CONTRAINDICATION; DRUG HALF LIFE; DRUG MECHANISM; ENERGY RESOURCE; FIBRINOLYTIC THERAPY; HEART FAILURE; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; HYPOTENSION; INTRACRANIAL PRESSURE; MEAN ARTERIAL PRESSURE; NEUROSURGERY; NONHUMAN; OUTCOME ASSESSMENT; PERFUSION PRESSURE; PRIORITY JOURNAL; RISK ASSESSMENT; STIMULUS RESPONSE; SURGICAL TECHNIQUE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BRAIN; CEREBROVASCULAR DISORDERS; HUMANS; NEUROSURGICAL PROCEDURES; VASOCONSTRICTOR AGENTS;

EID: 79954519129     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/jnis.2009.001206     Document Type: Article

References (43)

1. Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92.
2. Turan TN, Cotsonis G, Lynn MJ, et al; Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation 2007;115:2969-75.
3. Abou-Chebl A, Yadav JS, Reginelli JP, et al; Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment. J Am Coll Cardiol 2004;43:1596-601. (Pubitemid 38561339)
4. Lassen NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev 1959;39:183-238.
5. Rosner MJ. Introduction to cerebral perfusion pressure management. Neurosurg Clin North Am 1995;6:761-73.
6. Branston NM. Neurogenic control of the cerebral circulation. Cerebrovasc Brain Metab Rev 1995;7:338-49. (Pubitemid 3010772)
7. Dagal A, Lam AM. Cerebral autoregulation and anesthesia. Curr Opin Anaesthesiol 2009;22:547-52.
8. Cole CD, Gottfried ON, Gupta DK, et al. Total intravenous anesthesia: advantages for intracranial surgery. Neurosurgery 2007;61(5 Suppl 2):369-77; discussion 377-8.
9. Drummond JC, Dao AV, Roth DM, et al. Effect of dexmedetomidine on cerebral blood flow velocity, cerebral metabolic rate, and carbon dioxide response in normal humans. Anesthesiology 2008;108:225-32. (Pubitemid 351156732)
10. Abou-Chebl A, Lin R, Hussain MS, et al. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke. Preliminary results from a retrospective, multicenter study. Stroke 2010;41:1175-9.
11. Scheer B, Perel A, Pfeiffer UJ. Clinical review: complications and risk factors of peripheral arterial catheters used for haemodynamic monitoring in anaesthesia and intensive care medicine. Crit Care 2002;6:199-204.
12. White H, Venkatesh B. Cerebral perfusion pressure in neurotrauma: a review. Anesth Analg 2008;107:979-88.
13. Holmes CL, Walley KR. Vasoactive drugs for vasodilatory shock in ICU. Curr Opin Crit Care 2009;15:398-402.
14. Marik PE, Varon J. Perioperative hypertension: a review of current and emerging therapeutic agents. J Clin Anesth 2009;21:220-9.
15. Beale RJ, Hollenberg SM, Vincent JL, et al. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med 2004;32(11 Suppl): S455-65.
16. Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation 2008;118:176-87.
17. Leonardi-Bee J, Bath PM, Phillips SJ, et al; IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002;33:1315-20.
18. Aaslid R, Lindegaard KF, Sorteberg W, et al. Cerebral autoregulation dynamics in humans. Stroke 1989;20:45-52. (Pubitemid 19040212)
19. Mattle HP, Kappeler L, Arnold M, et al. Blood pressure and vessel recanalization in the first hours after ischemic stroke. Stroke 2005;36:264-8. (Pubitemid 40170805)
20. Zazulia AR, Videen TO, Powers WJ. Symptomatic autoregulatory failure in acute ischemic stroke. Neurology 2007;68:389-90. (Pubitemid 46184219)
21. Tsivgoulis G, Saqqur M, Sharma VK, et al. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke. Stroke 2007;38:961-6. (Pubitemid 46568459)
22. Nogueira RG, Liebeskind DS, Sung G, et al. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke 2009;40:3777-83.
23. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007;115:e478-534.
24. Khatri P, Wechsler LR, Broderick JP. Intracranial hemorrhage associated with revascularization therapies. Stroke 2007;38:431-40. (Pubitemid 46188260)
25. Schroeder T, Sillesen H, Sorensen O, et al. Cerebral hyperperfusion following carotid endarterectomy. J Neurosurg 1987;66:824-9. (Pubitemid 17085702)
26. Moulakakis KG, Mylonas SN, Sfyroeras GS, et al. Hyperperfusion syndrome after carotid revascularization. J Vasc Surg 2009;49:1060-8.
27. Ouriel K, Shortell CK, Illig KA, et al. Intracerebral hemorrhage after carotid endarterectomy: incidence, contribution to neurologic morbidity, and predictive factors. J Vasc Surg 1999;29:82-7; discussion 87-9.
28. Sundt TM Jr, Sharbrough FW, Piepgras DG, et al. Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy: with results of surgery and hemodynamics of cerebral ischemia. Mayo Clin Proc 1981;56:533-43. (Pubitemid 12230956)
29. Marks MP, Marcellus M, Norbash AM, et al. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 1999;30:1065-9. (Pubitemid 29211628)
30. Liu AY, Do HM, Albers GW, et al. Hyperperfusion syndrome with hemorrhage after angioplasty for middle cerebral artery stenosis. AJNR Am J Neuroradiol 2001;22:1597-601. (Pubitemid 32862277)
31. Connors JJ 3rd, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg 1999;91:415-23.
32. Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med 2006;354:387-96.
33. Mocco J, Rose JC, Komotar RJ, et al. Blood pressure management in patients with intracerebral and subarachnoid hemorrhage. Neurosurg Clin North Am 2006;17(Suppl 1):25-40.
34. Kassell NF, Torner JC, Haley EC Jr, et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 1990;73:18-36.
35. Keyrouz SG, Diringer MN. Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care 2007;11:220.
36. van den Bergh WM, Algra A, van Kooten F, et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 2005;36:1011-15.
37. Muench E, Horn P, Bauhuf C, et al. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med 2007;35:844-51; quiz 852.
38. Raabe A, Beck J, Keller M, et al. Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 2005;103:974-81.
39. Joseph M, Ziadi S, Nates J, et al. Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow. Neurosurgery 2003;53:1044-51; discussion 1051-2.
40. Ogilvy CS, Stieg PE, Awad I, et al. AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke 2001;32:1458-71.
41. Lee CZ, Young WL. Management of brain arteriovenous malformations. Curr Opin Anaesthesiol 2005;18:484-9.
42. Heidenreich JO, Hartlieb S, Stendel R, et al. Bleeding complications after endovascular therapy of cerebral arteriovenous malformations. AJNR Am J Neuroradiol 2006;27:313-16.
43. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation 2007;116:e391-413.